SCHEMBL2138951

SCHEMBL2138951

C1=CC2CC(CC1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1145504 0.83
SCHEMBL17966606 0.79
SCHEMBL3341030 0.77
SCHEMBL3632694 0.76 CHRNB2 (0.32)
SCHEMBL8961450 0.74
SCHEMBL477461 0.69
SCHEMBL375674 0.69
SCHEMBL5693030 0.69 ALDH1A1 (0.33)
SCHEMBL5693027 0.69 ALDH1A1 (0.33)
SCHEMBL5693106 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552000-B2 Therapeutic agent for senile dementia DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-10-08 US disclosed
US-20120165341-A1 THERAPEUTIC AGENT FOR SENILE DEMENTIA DAINIPPON SUMITOMO PHARMA CO., LTD. 2012-06-28 US disclosed
US-8148379-B2 Use of lurasidone (N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl-methyl]-1-cyclohexylmethyl]-2,3-bicycl[2.2.1]heptanedicarboxyimide) DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-04-03 US disclosed
US-20080255148-A1 Use of lurasidone (N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl-methyl]-1-cyclohexylmethyl]-2,3-bicycl[2.2.1]heptanedicarboxyimide) DAINPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-10-16 US disclosed
US-20060142276-A1 Therapeutic agent for senile dementia DAINIPPON SUMITOMO PHARMA CO. LTD. (JP) 2006-06-29 US disclosed
EP-1637530-A1 THERAPEUTIC AGENT FOR SENILE DEMENTIA Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-03-22 EP disclosed
EP-0464846-B1 Imide derivatives, and their production and use SUMITOMO PHARMA (JP) 1998-04-22 EP disclosed
US-5532372-A Imide derivatives, and their production and use SUMITOMO PHARMACEUTICALS COMPANY, LTD. (JP) 1996-07-02 US disclosed
EP-0464846-A1 Imide derivatives, and their production and use SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1992-01-08 EP disclosed